Formula1.jpg (Formula1)
Phenytoin Sodium Injection
Product Images NDC 0404-9932
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Phenytoin Sodium (NDC 0404-9932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
Table 1 shows a list of drugs that may increase or decrease phenytoin serum levels. The drugs are classified into different categories such as antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, and others. Antiepileptic drugs, azoles, antineoplastic agents, and a few other drugs may increase phenytoin serum levels, while antineoplastic agents in combination, antiviral agents, antiepileptic drugs, and a few other drugs may decrease serum levels. Some antiepileptic drugs may either increase or decrease the serum levels of phenytoin.*
Image2.jpg (Image2)
This is a table listing several drugs that can be affected by phenytoin, indicating either drugs that are paired with it or drugs whose level is decreased by it. The table describes the interacting agents and gives examples, along with some notes on their effects on drugs such as warfarin, antiepileptic drugs, calcium channel blockers, and so on. It also notes that the effect of phenytoin on phenobarbital, valproic acid, and sodium valproate serum levels is unpredictable.*
Image3.jpg (Image3)
This is a label for a product "manufactured by" a company called "WEST-WARD" located at "v, 1 07724 Ush". The label was revised in November 2017 and the product code is 6234810.*
Label1.jpg (Label1)
Phenytoin sodium is a medication available in a 100mg/2ml injection in a 2ml single dose vial, used intravenously for slow administration (not exceeding 50mg per minute). The solution contains phenytoin sodium (50mg/ml), propylene glycol (0.4ml) and alcohol (0.1ml) in water for injection, with pH adjusted with sodium hydroxide. The solution should not be used if hazy or has a precipitate, and the injection should be administered slowly. The medication should be stored at controlled room temperature, and kept out of reach of children. The manufacturer is Henry Schein, Inc, and the original manufacturing lot is indicated as XX—X0(—10C) with NDE 0641—049326. The text does not provide information regarding the therapeutic indications of the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
